Biosimilars

Biosimilars from Clarivate is a market intelligence solution designed to help life sciences organizations assess opportunities and threats within the rapidly evolving biosimilars landscape. It is built for pharmaceutical and biotech companies seeking to understand market size, refine market access strategies, and determine the most effective positioning for their brands in this competitive and lucrative segment.

By delivering comprehensive intelligence on the biosimilars market, the solution supports portfolio strategy, business development, and market assessment activities. Teams across commercial, strategic, and market access functions can leverage this tool to make informed decisions about where and how to compete.

Core Capabilities

• Assess the overall market size for biosimilars to quantify the scale of opportunity or competitive threat
• Optimize market access strategy by understanding the dynamics shaping biosimilar uptake and reimbursement
• Determine the best positioning for your brand relative to existing and emerging biosimilar competitors
• Size both opportunities and threats within the biosimilars space to support strategic planning and investment decisions

Who It Is For

• Pharmaceutical and biotechnology companies evaluating entry into the biosimilars market
• Originator biologic manufacturers monitoring competitive biosimilar threats to their portfolio
• Business development and portfolio strategy teams requiring robust market intelligence
• Market access professionals seeking data-driven insights to inform pricing and access strategies

Biosimilars is part of Clarivate's broader portfolio of life sciences and healthcare intelligence solutions, which includes platforms such as Cortellis and Market Access Intelligence, enabling organizations to connect biosimilar market insights with wider drug development and commercial strategy workflows.